Company Filing History:
7 out of 437 
2 out of 8 
1 out of 195 
Years Active: 2011-2021
Title: Ken-ichiro Hiwatari: Innovator in Biomaterials
Introduction
Ken-ichiro Hiwatari is a prominent inventor based in Tokyo, Japan. He has made significant contributions to the field of biomaterials, holding a total of eight patents. His work focuses on developing innovative solutions that enhance medical treatments and improve patient outcomes.
Latest Patents
Among his latest patents, Hiwatari has developed an anti-adhesion material and a substitute biomembrane using decellularized tissue. This anti-adhesion material comprises decellularized tissues combined with a biocompatible polymer or fibrin glue. He has also created a method for preparing this anti-adhesion material by complexing a biocompatible polymer or fibrin glue to decellularized tissues. Additionally, he has designed an anti-adhesion material kit that includes decellularized tissues and a biocompatible polymer or fibrin glue. His substitute biomembrane, which also utilizes decellularized tissues and a biocompatible polymer or fibrin glue, is accompanied by a method for its preparation and a corresponding kit. Furthermore, he has developed a polysaccharide derivative featuring a membrane-permeable peptide chain, which includes a partial structure represented by a specific formula.
Career Highlights
Throughout his career, Hiwatari has worked with notable companies such as Adeka Corporation and Josho Gakuen Educational Foundation. His experience in these organizations has allowed him to refine his expertise in biomaterials and contribute to various innovative projects.
Collaborations
Hiwatari has collaborated with esteemed colleagues, including Yoshikazu Shoji and Shinji Sakuma. These partnerships have fostered a collaborative environment that encourages the exchange of ideas and advancements in their respective fields.
Conclusion
Ken-ichiro Hiwatari is a distinguished inventor whose work in biomaterials has the potential to revolutionize medical treatments. His innovative patents and collaborations highlight his commitment to advancing healthcare solutions.